source
- Federal judge halts Colorado price cap on Amgen's Enbrel drugA U.S. district judge issued an injunction that stops the Colorado Prescription Drug Affordability Board from imposing a payment limit on Enbrel, a high-volume biologic sold by Amgen. The court fou…
- Former FDA AI regulator says biopharma is misreading agency's guidance, leading to overly cautious approachesTala Fakhouri, who wrote AI policy at the FDA, left the agency last summer and now serves as chief AI and regulatory strategy officer at contract research organization Parexel. She says biopharma…